- Report
- October 2023
- 159 Pages
Global
From €2335EUR$2,350USD£1,941GBP
- Report
- July 2022
- 150 Pages
Global
From €2235EUR$2,250USD£1,858GBP
- Report
- March 2022
- 75 Pages
Global
From €944EUR$950USD£785GBP
- Report
- December 2020
- 66 Pages
Global
From €844EUR$850USD£702GBP
- Report
- December 2020
- 64 Pages
United States
From €844EUR$850USD£702GBP
- Report
- June 2021
- 87 Pages
Global
€21856EUR$22,000USD£18,172GBP
- Report
- February 2021
- 35 Pages
Global
€1309EUR$1,318USD£1,089GBP
- Report
- February 2021
- 44 Pages
Global
€1309EUR$1,318USD£1,089GBP
- Drug Pipelines
- February 2019
- 300 Pages
Global
From €21856EUR$22,000USD£18,172GBP
- Report
- January 2019
- 14 Pages
United Kingdom
From €595EUR$599USD£495GBP
- Report
- July 2018
- 765 Pages
Global
From €21856EUR$22,000USD£18,172GBP
- Report
- June 2018
- 16 Pages
Global
From €9934EUR$10,000USD£8,260GBP
- Report
- June 2018
- 15 Pages
Global
From €9934EUR$10,000USD£8,260GBP
- Report
- March 2022
- 300 Pages
Global
From €3974EUR$4,000USD£3,304GBP
- Report
- September 2023
- 230 Pages
Global
From €2434EUR$2,450USD£2,024GBP
- Report
- February 2023
- 260 Pages
Global
From €2782EUR$2,800USD£2,313GBP
- Report
- October 2022
- 200 Pages
Global
From €2384EUR$2,400USD£1,982GBP
- Report
- January 2022
- 220 Pages
Global
From €2384EUR$2,400USD£1,982GBP
- Report
- December 2021
- 220 Pages
Global
From €2384EUR$2,400USD£1,982GBP
- Report
- July 2021
- 35 Pages
Global
The Central Nervous System Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs that target the central nervous system. These drugs are used to treat a variety of conditions, including neurological disorders, mental health issues, and pain management. The market is composed of a variety of companies, ranging from large multinationals to small start-ups.
The Central Nervous System Drugs market is highly competitive, with companies competing to develop the most effective and safe treatments. Companies in the market are constantly researching and developing new drugs, as well as improving existing treatments. Many of these companies are also involved in clinical trials to test the safety and efficacy of their products.
Some of the major companies in the Central Nervous System Drugs market include Pfizer, GlaxoSmithKline, Merck, Novartis, and Johnson & Johnson. These companies are involved in the development and production of a wide range of CNS drugs, including antidepressants, antipsychotics, and anticonvulsants. Show Less Read more